PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681433
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681433
The Global Near Infrared Imaging Market was valued at approximately USD 2.16 billion in 2023 and is projected to expand at a CAGR of 3.9% over the forecast period of 2024-2032. The increasing prevalence of cardiovascular diseases (CVDs), gastrointestinal conditions, neurovascular disorders, and cancer is fueling the demand for near-infrared imaging solutions. This imaging technology is widely used in surgical visualization, diagnostics, and physiological monitoring, making it indispensable in medical applications. Furthermore, rapid advancements in fluorescence imaging systems, AI-integrated imaging technologies, and portable diagnostic devices are strengthening market growth.
The post-pandemic resurgence in surgical interventions and minimally invasive procedures is another major driver for the market. With an increasing number of cosmetic, reconstructive, and tumor resection surgeries, hospitals and clinics are incorporating near-infrared imaging (NIR) for real-time visualization of blood flow, tumor margins, and organ function assessments. Additionally, the rising geriatric population worldwide is escalating the financial burden on healthcare systems, prompting investments in high-precision imaging techniques to enhance patient care. According to WHO estimates, the number of individuals aged 65 and above is expected to reach 1.5 billion by 2050, thereby increasing demand for advanced imaging technologies in elderly care.
Near-infrared imaging is widely adopted in preclinical research and pharmaceutical applications, particularly in drug development, neuroscience research, and vascular imaging. The ability of NIR fluorescence imaging to provide non-invasive, real-time visualization of biological tissues and physiological processes is significantly expanding its application scope. Moreover, continuous research efforts in neuroimaging, functional spectroscopy, and early-stage cancer detection are expected to boost market adoption further. Major players are investing in mergers and acquisitions to enhance their product portfolios, as demonstrated by Hamamatsu Photonics K.K.'s acquisition of NKT Photonics A/S in 2024, which aimed to strengthen its laser and photonics imaging capabilities.
Geographically, North America continues to dominate the market, holding over 40.6% market share in 2023, driven by technological advancements, high disposable income, and rapid adoption of AI-assisted imaging techniques. The U.S. market leads in NIR imaging adoption due to the high incidence of cancer, expanding reconstructive surgery landscape, and growing demand for minimally invasive procedures. Meanwhile, Asia-Pacific is poised to witness the fastest growth, fueled by rising healthcare investments, increasing medical tourism, and government-backed initiatives to develop affordable imaging solutions.
Major Market Players Included in This Report